- Home/In The News/Blog/2013/November
26
November2013
category:
503b CompoundingVictims in meningitis outbreak hope for criminal charges against compounding pharmacy
BOSTON — Dirk Thompson III doesn’t hold out much hope that he and the 750 other victims in a nationwide meningitis outbreak will ever see much, if any, compensation for the deaths and illnesses caused by tainted steroids. He hopes to find justice another way if criminal charges are brought against the principals of a […]
read more26
November2013
category:
503b CompoundingToday’s Shortages
ASHP/FDA Amifostine Injection Amino Acid Products Ampicillin Sulbactam aspirin Tablets (Buffered) Cefpodoxime Ciprofloxacin Immediate-Release Tablets Clindamycin Injection Estradiol Tablets Fluorouracil Injection
read more25
November2013
category:
503b CompoundingA New Development in Compounding Pharmacy Case
Boston’s U.S. attorney today will announce what authorities say is a new development in the probes into Framingham’s New England Compounding Center linked to last year’s fungal meningitis outbreak. The firm’s steroid drugs have been linked to 751 meningitis and other infections across the country. Surviving victims of last year’s meningitis outbreak are waiting to […]
read more